Muscular Dystrophy Clinical Trials

108 recruitingLast updated: June 18, 2026

There are 108 actively recruiting muscular dystrophy clinical trials across 32 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1, Phase 4. Top locations include Little Rock, Arkansas, United States, Chicago, Illinois, United States, Atlanta, Georgia, United States. Updated daily from ClinicalTrials.gov.


Muscular Dystrophy Trials at a Glance

108 actively recruiting trials for muscular dystrophy are listed on ClinicalTrialsFinder across 6 cities in 32 countries. The largest study group is Not Applicable with 21 trials, with the heaviest enrollment activity in Little Rock, Chicago, and Atlanta. Lead sponsors running muscular dystrophy studies include Italfarmaco, Radboud University Medical Center, and Boston Children's Hospital.

Browse muscular dystrophy trials by phase

Treatments under study

About Muscular Dystrophy Clinical Trials

Looking for clinical trials for Muscular Dystrophy? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Muscular Dystrophy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Muscular Dystrophy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 108 trials

Recruiting
Phase 1

A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy
Insmed Gene Therapy LLC12 enrolled10 locationsNCT06817382
Recruiting

A Remote Study Using Technology to Assess Outcomes in DMD

Duchenne Muscular Dystrophy (DMD)
University of Oxford60 enrolled1 locationNCT07423026
Recruiting
Phase 2

Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients

Duchenne Muscular DystrophyDMDNeuromuscular Diseases+2 more
Satellos Bioscience, Inc.51 enrolled21 locationsNCT07287189
Recruiting
Phase 3

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

Duchenne Muscular Dystrophy
Solid Biosciences Inc.80 enrolled5 locationsNCT07160634
Recruiting
Not Applicable

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

Amyotrophic Lateral SclerosisSpinal Cord Injurieslocked-in Syndrome+3 more
Leigh R. Hochberg, MD, PhD.27 enrolled6 locationsNCT00912041
Recruiting
Phase 3

A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

facioscapulohumeral muscular dystrophyFascioscapulohumeral Muscular DystrophyFacio-Scapulo-Humeral Dystrophy+14 more
Avidity Biosciences, Inc.200 enrolled46 locationsNCT07038200
Recruiting

Duchenne Electronic Health Record Study

Becker muscular dystrophyDuchenne Muscular Dystrophy (DMD)Dystrophinopathy+1 more
The Duchenne Registry2,500 enrolled10 locationsNCT07609394
Recruiting
Phase 3

Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)

Muscular Dystrophy, DuchenneDMDNeuromuscular Diseases (NMD)+10 more
Dyne Therapeutics90 enrolled1 locationNCT07608432
Recruiting

Wearable Technology to Evaluate Hyperglycemia and HRV in DMD

Duchenne Muscular Dystrophy
Vanderbilt University Medical Center80 enrolled1 locationNCT06124196
Recruiting
Not Applicable

Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers

Myotonic DystrophyMuscular DystrophyCharcot-Marie-Tooth+1 more
Institut de Myologie, France30 enrolled1 locationNCT07321977
Recruiting
Phase 1Phase 2

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45

Duchenne Muscular Dystrophy (DMD)
Entrada Therapeutics, Inc.24 enrolled15 locationsNCT07038824
Recruiting
Not Applicable

The Effect of Virtual Reality Applications on Upper Extremity Functions in Patients With Duchenne Muscular Dystrophy

Virtual RealityDuchenne Muscular Dystrophy (DMD)
Istanbul University36 enrolled1 locationNCT07039799
Recruiting
Phase 2

Vasodilator and Exercise Study for DMD (VASO-REx)

ExerciseDuchenne Muscular DystrophyDMD+4 more
University of Florida50 enrolled1 locationNCT06290713
Recruiting
Not Applicable

Nomad P-KAFO Study

Multiple SclerosisSpinal Cord InjuriesCerebrovascular Accident+3 more
Shirley Ryan AbilityLab36 enrolled1 locationNCT05644522
Recruiting
Phase 1Phase 2

A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

Duchenne Muscular Dystrophy
Solid Biosciences Inc.60 enrolled15 locationsNCT06138639
Recruiting

The Duchenne Registry

Becker muscular dystrophyDuchenne Muscular DystrophyDystrophinopathy+2 more
The Duchenne Registry10,000 enrolled1 locationNCT02069756
Recruiting
Early Phase 1

Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients

Duchenne Muscular Dystrophy (DMD)
Shanghai Siponuoyin Biotechnology Co Ltd9 enrolled1 locationNCT07188012
Recruiting
Phase 1Phase 2

PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)

Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD
Precision BioSciences, Inc.18 enrolled1 locationNCT07429240
Recruiting

The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy (DMD)
University of Rochester105 enrolled1 locationNCT07092540
Recruiting

Investigational Use of Neuromuscular Ultrasound

Peripheral NeuropathyNormal PhysiologyMuscular Dystrophy+1 more
National Institute of Neurological Disorders and Stroke (NINDS)150 enrolled1 locationNCT05237973